BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24011204)

  • 1. [Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].
    Würtz M; Grove EL
    Ugeskr Laeger; 2013 Sep; 175(37):2094-8. PubMed ID: 24011204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
    [No Abstract]   [Full Text] [Related]  

  • 3. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Circulation; 2010 Dec; 122(24):2619-33. PubMed ID: 21060077
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myocardial infarction: Role of new antiplatelet agents].
    Silvain J; Bellemain A; Ecollan P; Montalescot G; Collet JP
    Presse Med; 2011 Jun; 40(6):615-24. PubMed ID: 21511430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
    Agewall S; Cattaneo M; Collet JP; Andreotti F; Lip GY; Verheugt FW; Huber K; Grove EL; Morais J; Husted S; Wassmann S; Rosano G; Atar D; Pathak A; Kjeldsen K; Storey RF;
    Eur Heart J; 2013 Jun; 34(23):1708-13, 1713a-1713b. PubMed ID: 23425521
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiplatelet therapy in coronary heart disease. Some problems and achivements].
    Gratsianskiĭ NA
    Kardiologiia; 2010; 50(6):4-21. PubMed ID: 20659022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
    Würtz M; Grove EL
    Adv Exp Med Biol; 2017; 906():325-350. PubMed ID: 27628008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
    Alexopoulos D; Goudevenos JA; Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Parissis H; Ntalas IV; Angelidis C; Petousis S; Vavuranakis M; Hahalis G; Stefanadis C;
    Int J Cardiol; 2013 Oct; 168(6):5329-35. PubMed ID: 23978364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
    Serebruany VL; Dinicolantonio JJ; Can MM; Pershukov IV; Kuliczkowski W
    Cardiology; 2013; 126(1):35-40. PubMed ID: 23860246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
    Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
    Clemmensen P; Dridi NP; Holmvang L
    Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary heart disease - what is of importance after coronary intervention?].
    Rassaf T; Hamm CW
    Dtsch Med Wochenschr; 2011 Feb; 136(5):190-3. PubMed ID: 21271479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet options for secondary prevention in acute coronary syndromes.
    Silvain J; Cayla G; O'Connor SA; Collet JP; Montalescot G
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1403-15. PubMed ID: 22059790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prominent features of management strategies in acute coronary syndromes with the new oral antiplatelet agents].
    Enar R
    Turk Kardiyol Dern Ars; 2013 Mar; 41(2):166-71. PubMed ID: 23666308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel.
    Kirkby NS; Leadbeater PD; Chan MV; Nylander S; Mitchell JA; Warner TD
    J Thromb Haemost; 2011 Oct; 9(10):2103-5. PubMed ID: 21812912
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications.
    Fitchett D; Mazer CD; Eikelboom J; Verma S
    Can J Cardiol; 2013 Sep; 29(9):1042-7. PubMed ID: 23642333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.